News Detail
Solan, 15 May 2024: The working of the Drug Control Administration (DCA), Baddi, has come under the scanner as despite large-scale sale of psychotropic drugs in the last one year, the management of Biogenetic Drugs Private Limited failed to disclose details of the buyers to the a......
View Details
Source : The Tribune
Drug Control Administration (DCA) Baddi
Biogenetic Drugs Private Limited
psychotropic drugs
Special Task Force
alprazolam 0.5 tablets
Related News
- DCA of Telangana seized misbranded cosmetics, three drugs for misleading claims, drugs from quacks clinic and Ferrvis-XT Tab (31-08-2024)
- Falling API prices signal Chinese predatory play (31-08-2024)
- Delhi HC issues interim order related to FDC ban based on several petitions (31-08-2024)
- Hyderabad: Mehendi cone manufacturing facility raided in Mangalhat (31-08-2024)
- Renata Medical Receives FDA Approval for the Minima Growth Stent (31-08-2024)
- DoP again extends deadline for self-declaration by companies (31-08-2024)
- Presence of microplastics in salt sugar brands NGT issues notice to authorities (31-08-2024)
- Non-vegetarian ingredient in herbal tooth powder, Delhi HC issues notice to Patanjali Ayurveda and Baba Ramdev (31-08-2024)
- Revised GMP norms for small drug firms to be issued soon (30-08-2024)
- CDSCO launched series of digital initiatives to streamline pharmaceutical regulations: DCGI (30-08-2024)